Pre-Tax Income: Company's earnings or loss before taxes on income have been accounted for.
Tenaya Therapeutics, Inc. (TNYA) had Pre-Tax Income of $-43.39M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$1.11M |
|
$-43.39M |
|
-- |
|
$1.11M |
|
$45.20M |
|
$-44.09M |
|
$0.69M |
|
|
Pre-Tax Income |
$-43.39M |
$-43.39M |
|
$-43.39M |
|
$-43.39M |
|
$-43.39M |
|
$-43.39M |
|
$-44.09M |
|
$-42.39M |
|
217.57M |
|
217.57M |
|
$-0.20 |
|
$-0.20 |
|
| Balance Sheet Financials | |
$86.01M |
|
$2.49M |
|
$7.53M |
|
$93.54M |
|
$19.02M |
|
-- |
|
$5.11M |
|
$24.13M |
|
$69.41M |
|
$69.41M |
|
$69.41M |
|
224.23M |
|
| Cash Flow Statement Financials | |
$-22.79M |
|
$-0.17M |
|
$0.49M |
|
$100.97M |
|
$78.50M |
|
$-22.46M |
|
$3.90M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.52 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-3971.89% |
|
-3971.89% |
|
-- |
|
-3909.28% |
|
-3909.28% |
|
$-22.96M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
2.99 |
|
30.08 |
|
-62.52% |
|
-62.52% |
|
-46.39% |
|
-62.52% |
|
$0.31 |
|
$-0.11 |
|
$-0.10 |
|